Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $477B
1-Year Est. Return 23.58%
 

Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+23.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$466B
AUM Growth
+$34.1B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,356
New
Increased
Reduced
Closed

Top Buys

1 +$520M
2 +$440M
3 +$293M
4
AVGO icon
Broadcom
AVGO
+$268M
5
MSFT icon
Microsoft
MSFT
+$256M

Top Sells

1 +$453M
2 +$237M
3 +$217M
4
SKX
Skechers
SKX
+$201M
5
COF icon
Capital One
COF
+$187M

Sector Composition

1 Technology 21.96%
2 Financials 18%
3 Industrials 12%
4 Consumer Discretionary 10.49%
5 Healthcare 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHLD
3301
DELISTED
Guild Holdings
GHLD
-13,852
GMS
3302
DELISTED
GMS Inc
GMS
-1,991,418
GNSS icon
3303
Genasys
GNSS
$89.1M
-84,050
GOGL
3304
DELISTED
Golden Ocean Group
GOGL
-13,883
HES
3305
DELISTED
Hess
HES
-3,269,274
HLVX
3306
DELISTED
HilleVax
HLVX
-61,542
HOOK
3307
DELISTED
HOOKIPA Pharma
HOOK
-23,948
ICAD
3308
DELISTED
iCAD Inc
ICAD
-159,378
IMA
3309
ImageneBio Inc
IMA
$76.6M
-3,218
IMUX icon
3310
Immunic
IMUX
$105M
-13,151
INZY
3311
DELISTED
Inozyme Pharma
INZY
-120,145
ITOS
3312
DELISTED
iTeos Therapeutics
ITOS
-832,761
JNPR
3313
DELISTED
Juniper Networks
JNPR
-2,949,539
KLG
3314
DELISTED
WK Kellogg Co
KLG
-1,247,210
MAG
3315
DELISTED
MAG Silver
MAG
-125,061
LITS
3316
Lite Strategy Inc
LITS
$37.9M
-23,427
MGTX icon
3317
MeiraGTx Holdings
MGTX
$592M
-149,766
MODV
3318
DELISTED
ModivCare
MODV
-123,916
MRKR icon
3319
Marker Therapeutics
MRKR
$24M
-15,900
NKTR icon
3320
Nektar Therapeutics
NKTR
$1.44B
-14,380
NVEE
3321
DELISTED
NV5 Global
NVEE
-2,870,793
NVNO icon
3322
enVVeno Medical
NVNO
$6.03M
-461
OBIO icon
3323
Orchestra BioMed
OBIO
$216M
-22,207
OLO
3324
DELISTED
Olo Inc
OLO
-3,523,547
OPOF
3325
DELISTED
Old Point Financial
OPOF
-21,904